Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
3.29%
↓ 100% below average
Average (39q)
3764.05%
Historical baseline
Range
High:172417.24%
Low:-22693.33%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 3.29% |
| Q2 2025 | 16.70% |
| Q1 2025 | -0.78% |
| Q4 2024 | -12.02% |
| Q3 2024 | 27.86% |
| Q2 2024 | 13.47% |
| Q1 2024 | 7.18% |
| Q4 2023 | -16.85% |
| Q3 2023 | 19.57% |
| Q2 2023 | 17.49% |
| Q1 2023 | 25.54% |
| Q4 2022 | -49.24% |
| Q3 2022 | 100.56% |
| Q2 2022 | 24.44% |
| Q1 2022 | -6.78% |
| Q4 2021 | 59.04% |
| Q3 2021 | 128.34% |
| Q2 2021 | 628.87% |
| Q1 2021 | -98.27% |
| Q4 2020 | 172417.24% |
| Q3 2020 | 0.00% |
| Q2 2020 | -3.33% |
| Q1 2020 | 100.23% |
| Q4 2019 | 24.47% |
| Q3 2019 | -57.88% |
| Q2 2019 | -4.92% |
| Q1 2019 | 1.93% |
| Q4 2018 | -0.31% |
| Q3 2018 | -2.88% |
| Q2 2018 | -18.27% |
| Q1 2018 | -2.27% |
| Q4 2017 | 19.65% |
| Q3 2017 | -59.01% |
| Q2 2017 | -22693.33% |
| Q1 2017 | 3.45% |
| Q4 2016 | -3.33% |
| Q3 2016 | -44.44% |
| Q2 2016 | -3.57% |
| Q1 2016 | 1.82% |
| Q4 2015 | -1.79% |